C96.A
BillableHistiocytic sarcoma
HCC Category Mapping
V28HCC 21 — Breast, Prostate, Colorectal and Other Cancers and Tumors
0.545V24HCC 10 — Lymphoma and Other Cancers
0.675ESRDHCC 10 — Lymphoma and Other Cancers
0.000RxHCCHCC 21 — Hodgkin Lymphoma and Other Cancers
0.000What This Code Means
A rare cancer that develops from histiocytes, which are immune cells found in various tissues throughout the body.
Coding Tips
- •Histiocytic sarcoma is a specific diagnosis that should be clearly documented in the pathology report
- •Ensure the diagnosis specifies histiocytic sarcoma rather than other histiocytic disorders to use this code
Clinical Significance
Histiocytic sarcoma is an extremely rare and aggressive malignancy arising from mature histiocytes/macrophages, accounting for less than 1% of hematolymphoid neoplasms. It typically presents with extranodal masses, constitutional symptoms, and can involve the gastrointestinal tract, skin, soft tissue, or central nervous system. Prognosis is generally poor, with most patients requiring aggressive multiagent chemotherapy.
Documentation Requirements
- ✓Definitive diagnosis requires pathologic confirmation with immunohistochemistry showing expression of histiocytic markers (CD68, CD163, lysozyme) and absence of Langerhans-cell markers (CD1a, langerin) and follicular dendritic cell markers.
- ✓Documentation should include the primary site of involvement, staging workup results, and treatment plan.
- ✓The provider must clearly state 'histiocytic sarcoma' rather than generic histiocytic disorder terminology.
Commonly Confused Codes
C96.Z (other specified malignant neoplasms) may be confused when the specific histiocytic subtype is unclearC96.5/C96.6 (Langerhans-cell histiocytosis) are distinct entities with different immunophenotypeC83.3 (diffuse large B-cell lymphoma) can morphologically mimic histiocytic sarcoma and requires immunohistochemistry to differentiate.